Citation Impact
Citing Papers
Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease–Associated Colorectal Cancer
2009 StandoutNobel
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Colorectal cancer statistics, 2014
2014 Standout
Colorectal cancer statistics, 2020
2020 Standout
Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
2014 Standout
Colorectal cancer statistics, 2023
2023 Standout
Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication
2018 StandoutNobel
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Gastric cancer
2016 Standout
Astrocytes: biology and pathology
2009 Standout
An overview of clinical decision support systems: benefits, risks, and strategies for success
2020 Standout
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis
2007
The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological role
2011 Standout
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
2014 Standout
Role for epithelial dysregulation in early-onset colitis-associated colon cancer in Gi2-alpha−/− mice
2008 StandoutNobel
Crohn’s Disease and Ulcerative Colitis Are Associated With Elevated Standardized Mortality Ratios
2013
Ulcerative Colitis
2011 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Role of Imaging in the Era of Precision Medicine
2017
Disparities in survival improvement for metastatic colorectal cancer by race/ethnicity and age in the United States
2014
Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: A nationwide Japanese study
2010
Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
2009
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
2010 Standout
Acute-on chronic liver failure
2012
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Radioembolization with Yttrium-90 Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies
2006
Chemotherapy for advanced gastric cancer
2010
Treatments for colorectal liver metastases: A new focus on a familiar concept
2016
Mechanisms of intestinal inflammation and development of associated cancers: Lessons learned from mouse models
2010
Chemotherapy for advanced gastric cancer
2005
Checking consistency in mixed treatment comparison meta‐analysis
2010 Standout
Colorectal cancer
2019 Standout
Cancer-associated cachexia
2018 Standout
Inflammation and Colon Cancer
2010 Standout
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
2006
Ulcerative colitis
2012 Standout
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
Adjuvant Therapy for Colon Cancer 2005: New Options in the Twenty-First Century
2006
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
How were new medicines discovered?
2011 Standout
Ulcerative colitis
2016 Standout
A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment
2013
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Chronic ulcerative colitis and colorectal cancer
2013
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
SCEW: A Microsoft Excel add-in for easy creation of survival curves
2006
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Surveillance of Patients at Increased Risk of Colon Cancer: Inflammatory Bowel Disease and Other Conditions
2008
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
2008
Targeted Therapy for Malignant Glioma Patients: Lessons Learned and the Road Ahead
2009
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
2010 Standout
The global burden of IBD: from 2015 to 2025
2015 Standout
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
2013
Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies
2006
Pathology of Dysplasia and Cancer in Inflammatory Bowel Disease
2006
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Impact of high-throughput screening in biomedical research
2011 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Natural Polyphenols for Prevention and Treatment of Cancer
2016 Standout
Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data
2006
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
2009 Standout
Resveratrol induces gastric cancer cell apoptosis via reactive oxygen species, but independent of sirtuin1
2011
What has preoperative radio(chemo)therapy brought to localized rectal cancer patients in terms of perioperative and long‐term outcomes over the past decades? A systematic review and meta‐analysis based on 41,121 patients
2017
Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
2008
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Colorectal cancer statistics, 2017
2017 Standout
Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies
2008
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
2017 Standout
Necitumumab for the Treatment of Advanced Non-Small-Cell Lung Cancer
2018
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
2016 Standout
Fisetin inhibits cellular proliferation and induces mitochondria‐dependent apoptosis in human gastric cancer cells
2016
A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG1 Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies
2010
Flavonoids in Cancer and Apoptosis
2018 Standout
Survival Following Recurrence in Stage II and III Colon Cancer: Findings From the ACCENT Data Set
2008
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
2015 Standout
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
2009
Phage display-derived human antibodies in clinical development and therapy
2016
Works of Thierry Delaunoit being referenced
Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer
2016
Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer
2016
Pathogenesis and Risk Factors of Small Bowel Adenocarcinoma: A Colorectal Cancer Sibling?
2005
A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors
2006
Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study
2011
Colorectal Cancer Prognosis Among Patients With Inflammatory Bowel Disease
2006
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741
2005
Mortality associated with daily bolus 5‐fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin
2004
Somatostatin Analogues in the Treatment of Gastroenteropancreatic Neuroendocrine Tumors
2005
Latest developments and emerging treatment options in the management of stomach cancer
2011
Latest developments and emerging treatment options in the management of stomach cancer
2011
SoMore trial: Early metabolic response assessment of a sorafenib (SOR) and capecitabine (CAP) combination in chemorefractory metastatic colorectal cancer (mCRC).
2014
A phase II multicenter study evaluating the efficacy and safety of IMC-11F8, a recombinant human IgG1 anti- epidermal growth factor receptor (EGFR) monoclonal antibody (Mab), combined with 5-FU/FA and oxaliplatin (mFOLFOX-6) as first- line therapy
2008
Acute upper gastrointestinal bleeding in cirrhosis: changes and advances over the past two decades.
2011
Medical Management of Pancreatic Neuroendocrine Tumors
2007
381 A phase I study of BAY 43-90006, a novel Raf kinase and VEGFR inhibitor, in combination with taxotere in patients with advanced solid tumors
2004
Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy
2010